Quarterly report pursuant to Section 13 or 15(d)

Note 1 - Nature of Business and Significant Accounting Policies (Details)

v3.8.0.1
Note 1 - Nature of Business and Significant Accounting Policies (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Dec. 10, 2014
shares
Nov. 12, 2014
shares
Feb. 28, 2018
USD ($)
Feb. 28, 2017
USD ($)
Feb. 28, 2018
USD ($)
Feb. 28, 2017
USD ($)
May 31, 2015
USD ($)
May 31, 2017
USD ($)
May 31, 2016
USD ($)
Note 1 - Nature of Business and Significant Accounting Policies (Details) [Line Items]                  
Stockholders' Equity Note, Stock Split, Conversion Ratio 0.625                
Stock Issued During Period, Value, New Issues             $ 15,000,000    
Cash and Cash Equivalents, at Carrying Value     $ 22,733 $ 5,940 $ 22,733 $ 5,940   $ 78,310 $ 88,244
Advertising Expense     0 0 0 0      
Research and Development Expense     $ 0 $ 0 $ 0 $ 0      
Shares of CLS Holdings USA, Inc. [Member] | CLS Labs, Inc. [Member]                  
Note 1 - Nature of Business and Significant Accounting Policies (Details) [Line Items]                  
Subsidiary or Equity Method Investee, Cumulative Number of Shares Issued for All Transactions (in Shares) | shares 6,250,000 10,000,000              
Equity Method Investment, Ownership Percentage   55.60%